Transbronchoscopic Emphysema Treatment with One-Way Zephyr Valves

  • Amarilio Vieira de Macedo-Neto
  • Hugo G. de Oliveira
Chapter

Abstract

Few alternatives are available for emphysema treatment. The high mortality associated with volume reduction surgery (LVRS) and lung transplantation has greatly restricted their applicability. As a result, minimally invasive alternatives have been developed using the same rationale underlying LVRS—to decrease or prevent air trapping in lung that is damaged by emphysema with reexpansion of the remaining tissue. This chapter will focus on one of these minimally invasive approaches, namely, transbronchoscopic placement of one-way valves. This technique is safe and reversible, although it is still limited by the absence of a clear understanding regarding the best selection criteria. This gap is due in part to a poorly designed trial, which ended up slowing down the acceptance of this promising technique.

Keywords

Catheter Hydration Depression Cage Hydroxide 

Notes

Acknowledgments

Editorial support was provided by Claudia Buchweitz.

Bibliography

  1. 1.
    National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001;345: 1075–83.CrossRefGoogle Scholar
  2. 2.
    The National Emphysema Treatment Trial Research Group. Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. Chest. 1999;116:1750–61.CrossRefGoogle Scholar
  3. 3.
    Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The National Emphysema Treatment Trial (NETT) Part II: lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med. 2011;184:881–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema. Am J Respir Crit Care Med. 2011;184:763–70.PubMedCrossRefGoogle Scholar
  5. 5.
    Crenshaw GL. Bronchial stenosis produced endoscopically to destroy space-consuming bullae. Geriatrics. 1966;21:167–70.PubMedGoogle Scholar
  6. 6.
    Watanabe Y, Matsuo K, Tamaoki A, Komoto R, Hiraki S. Bronchial occlusion with endobronchial Watanabe spigot. J Bronchol. 2003;10:264–7.CrossRefGoogle Scholar
  7. 7.
    Venuta F, de Giacomo T, Rendina EA, Ciccone AM, Diso D, Perrone A, et al. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. Ann Thorac Surg. 2005;79: 411–6. discussion 6–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Wan IY, Toma TP, Geddes DM, Snell G, Williams T, Venuta F, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest. 2006;129:518–26.PubMedCrossRefGoogle Scholar
  9. 9.
    Toma TP, Hopkinson NS, Hillier J, Hansell DM, Morgan C, Goldstraw PG, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet. 2003;361:931–3.PubMedCrossRefGoogle Scholar
  10. 10.
    de Oliveira HG, Macedo-Neto AV, John AB, Jungblut S, Prolla JC, Menna-Barreto SS, et al. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest. 2006;130:190–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Travaline JM, McKenna Jr RJ, De Giacomo T, Venuta F, Hazelrigg SR, Boomer M, et al. Treatment of persistent pulmonary air leaks using endobronchial valves. Chest. 2009;136:355–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Ferguson JS, Sprenger K, Van Natta T. Closure of a bronchopleural fistula using bronchoscopic placement of an endobronchial valve designed for the treatment of emphysema. Chest. 2006;129:479–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Gillespie CT, Sterman DH, Cerfolio RJ, Nader D, Mulligan MS, Mularski RA, et al. Endobronchial valve treatment for prolonged air leaks of the lung: a case series. Ann Thorac Surg. 2011;91:270–3.PubMedCrossRefGoogle Scholar
  14. 14.
    Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363:1233–44.PubMedCrossRefGoogle Scholar
  15. 15.
    O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770–7.PubMedGoogle Scholar
  16. 16.
    Lynch DA, Newell JD. Quantitative imaging of COPD. J Thorac Imaging. 2009;24:189–94.PubMedCrossRefGoogle Scholar
  17. 17.
    Bergin C, Muller N, Nichols DM, Lillington G, Hogg JC, Mullen B, et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis. 1986;133:541–6.PubMedGoogle Scholar
  18. 18.
    Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379–87.PubMedCrossRefGoogle Scholar
  19. 19.
    Gompelmann D, Eberhardt R, Slebos D-J, Ficker J, F R, Schmidt B, et al. Study of the use of Chartis® pulmonary assessment system to optimize subject ­selection for endobronchial lung volume reduction (ELVR)-results and subgroup analysis. Chest. 2011; 140:546A.CrossRefGoogle Scholar
  20. 20.
    Kim V, Criner GJ, Abdallah HY, Gaughan JP, Furukawa S, Solomides CC. Small airway morphometry and improvement in pulmonary function after lung volume reduction surgery. Am J Respir Crit Care Med. 2005;171:40–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Hogg JC, Chu FS, Tan WC, Sin DD, Patel SA, Pare PD, et al. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med. 2007;176:454–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29:527–34.PubMedCrossRefGoogle Scholar
  23. 23.
    Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–504.PubMedCrossRefGoogle Scholar
  24. 24.
    Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.PubMedCrossRefGoogle Scholar
  25. 25.
    Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–38.PubMedCrossRefGoogle Scholar
  26. 26.
    Mair G, Maclay J, Miller JJ, McAllister D, Connell M, Murchison JT, et al. Airway dimensions in COPD: relationships with clinical variables. Respir Med. 2010;104:1683–90.PubMedCrossRefGoogle Scholar
  27. 27.
    Almagro P, Calbo E, de Ochoa Echaguen A, Barreiro B, Quintana S, Heredia JL, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Ferguson JS, McLennan G. Virtual bronchoscopy. Proc Am Thorac Soc. 2005;2(488–91):504–5.Google Scholar
  29. 29.
    Venuta F, Rendina EA, Coloni GF. Endobronchial treatment of emphysema with one-way valves. Thorac Surg Clin. 2009;19:255–60. x.PubMedCrossRefGoogle Scholar
  30. 30.
    Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37:1346–51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Amarilio Vieira de Macedo-Neto
    • 1
  • Hugo G. de Oliveira
    • 2
  1. 1.Department of Thoracic SurgeryHospital de Clinicas de Porto AlegrePorto AlegreBrazil
  2. 2.Emphysema Treatment GroupHospital Moinhos de VentoPorto AlegreBrazil

Personalised recommendations